GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kawamoto Corp (TSE:3604) » Definitions » Debt-to-EBITDA

Kawamoto (TSE:3604) Debt-to-EBITDA : 7.36 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Kawamoto Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Kawamoto's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円3,768 Mil. Kawamoto's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円2,991 Mil. Kawamoto's annualized EBITDA for the quarter that ended in Dec. 2023 was 円918 Mil. Kawamoto's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 7.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Kawamoto's Debt-to-EBITDA or its related term are showing as below:

TSE:3604' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -103.91   Med: 8.7   Max: 44.98
Current: 8.69

During the past 13 years, the highest Debt-to-EBITDA Ratio of Kawamoto was 44.98. The lowest was -103.91. And the median was 8.70.

TSE:3604's Debt-to-EBITDA is ranked worse than
92.18% of 435 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs TSE:3604: 8.69

Kawamoto Debt-to-EBITDA Historical Data

The historical data trend for Kawamoto's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kawamoto Debt-to-EBITDA Chart

Kawamoto Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.35 12.66 3.53 4.39 4.74

Kawamoto Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 6.30 18.30 7.80 7.36

Competitive Comparison of Kawamoto's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Kawamoto's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kawamoto's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kawamoto's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kawamoto's Debt-to-EBITDA falls into.



Kawamoto Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Kawamoto's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3747.04 + 2465.166) / 1311.495
=4.74

Kawamoto's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3768.124 + 2990.537) / 918.3
=7.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Kawamoto  (TSE:3604) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Kawamoto Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kawamoto's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Kawamoto (TSE:3604) Business Description

Traded in Other Exchanges
N/A
Address
2-6-4 Tanimachi, Tanimachi Building, chuo-ku, Osaka, JPN, 540-0012
Kawamoto Corp is engaged in the manufacturing, sale, and purchase of sanitary materials, medical supplies, pharmaceuticals, nursing care products, baby goods, clothing items in Japan. It offers surgical sponges for laparoscopic surgery; neurosurgical pads; oral care products. It also provides disposable medical products, including syringes, needles, dental needles, and others.

Kawamoto (TSE:3604) Headlines

No Headlines